The Department of Medicine - Internal Medicine Residency
The Department of Medicine started the first in-hospital residency training program in the country in 1823, with two residents who were required to pay $300 to cover their training expenses. Over the years, professors in medicine made significant contributions to the field of infectious diseases, including discovering the cause of an outbreak of yellow fever in Baltimore in the late 19th century.
Under the 32 year chairmanship of Dr. Maurice C. Pincoffs in the early to mid-1900's, the Department blossomed with a large clinical service and substantial commitment to teaching residents and students. Dr. Theodore E. Woodward joined the Department in 1948 as the first full-time faculty member and aided Dr. Pincoffs in reorganizing the Department into subspecialty divisions. Dr. Woodward was appointed the first full-time professor and Chairman of the Department in 1954 and guided its development until 1981.
In 1984, Dr. John A. Kastor assumed the chairmanship and recruited prominent research and clinical faculty doubling the size of the Department. Dr. William L. Henrich served as Chairman of the Department of Medicine from 1999 until 2006. During his tenure, the Department made huge strides in expanding the clinical enterprise to nearly 200 faculty members and increasing the amount of federally funded research. Dr. Frank M. Calia, served as Chairman from 2006 through 2009, and maintained the high level of excellence in clinical practice and research in the Department. His enduring legacy remains his passionate commitment to teaching medical students and residents.
As part of the University of Maryland School of Medicine, the Department of Medicine is a powerhouse of research activities. With over $182 million in annual direct grant and contract support, the Department has about 62 NIH RO1 awards, over 500 active research awards, including a GCRC, Pepper Center for Geriatric Research and Education, collaborative projects to study COPD and diabetes, 12 NIH funded K awards, 5 VA Career development awards, and several NIH-funded training grants. We are very proud of our national research ranking for NIH grants. Currently our Department is ranked in # of 138 medical schools and #6 of 76 for public medical schools in the US. Our faculty now number 350 full-time and 48 part-time faculty members, with nearly 300 volunteer faculty. Our emphasis on excellence in education and research fosters a strong academic and patient care environment for residency training in general medicine and the subspecialties.
Stephen N. Davis, MBBS, FRCP, FACP, was named as the Theodore E. Woodward Professor and Chairman in December 2009, and serves as Physician-in-Chief of the University of Maryland Medical Center. Dr. Davis, an internationally recognized endocrinologist and research scientist, was recruited from Vanderbilt University School of Medicine. As the Department of Medicine's 13th chair, he leads the School of Medicine's largest department, with over 300 full-time faculty. He has devoted his career to research and patient care, focusing on treating adults with diabetes and metabolic disorders, as well as studying the biological basis of certain diabetes-related complications.
A native of the United Kingdom, Dr. Davis earned his medical degree from the University of London's Royal Free Hospital School of Medicine and did his specialty training at the Royal College of Physicians. Dr. Davis joined Vanderbilt University School of Medicine in 1988. He was promoted to director of the Division of Diabetes, Endocrinology and Metabolism, and professor of medicine, molecular physiology and biophysics. Most recently, he also served as associate director of the General Clinical Research Center at Vanderbilt, and for five years, ending in 2002, he was director of the Nashville Veterans Affairs/Juvenile Diabetes Foundation International Research and Training Center.
He has been recognized with many distinguished awards throughout his career, including the Novartis Award for Diabetes Research in 2000 - considered to be the highest honor in that field of research. He was named a Fellow of the American College of Physicians in 2009, a Fellow of the American College of Endocrinologists in 2008 and a Fellow of the Royal College of Physicians in 2001.
Dr. Davis currently leads research projects with extramural funding totaling $10 million. His research focuses on the mechanisms that defend against hypoglycemia. Dr. Davis also explores the mechanisms that cause increased myocardial infarctions and strokes in diabetic patients. Dr. Davis is the author of more than 110 peer-reviewed articles and 50 textbook chapters and review articles.